Tuberculosis News and Research

Latest Tuberculosis News and Research

World's smallest and lightest microscope for telemedicine applications

Aydogan Ozcan, whose invention of a novel lensless imaging technology for use in telemedicine could radically transform global health care, has now taken his work a step further ― or tinier: The UCLA engineer has created a miniature microscope, the world's smallest and lightest for telemedicine applications.

23 Apr 2010

New USG strategy to combat malaria globally

In conjunction with World Malaria Day, and in accordance with the requirements of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008 (Lantos-Hyde), the U.S. Government, through the President's Malaria Initiative, today released a comprehensive strategy to combat malaria globally.

23 Apr 2010

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced it has received important commitments from two leading research laboratories in India for clinical validation testing for malaria and tuberculosis (TB) detection and diagnosis.

21 Apr 2010

Initial results of gallium-containing compound to treat serious infection presented at AACR 2010

Genta Incorporated today announced the presentation of initial results from the first human use of a gallium-containing compound to treat serious infection. In a patient with cystic fibrosis and a highly resistant lung infection, who has been treated over a 2-year period, high concentrations of gallium were achieved in sputum.

21 Apr 2010

Biomagnetics Diagnostics obtains handheld IOBS unit to detect pathogens

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced it has received its first handheld integrated optical biosensor unit from Los Alamos National Security, LLC.

21 Apr 2010

Report details progress in fighting malaria in Africa, notes funding shortfall

Global funding for malaria reached $1.7 billion in 2009, a "ten-fold" increase since 2004, and the production of insecticide-treated nets (ITNs) worldwide rose to 150 million last year, according to a report, released Monday, from UNICEF and the Roll Back Malaria (RBM) partnership, which also highlighted the need for additional funding, Agence France-Presse reports (4/19).

21 Apr 2010

Enhancing drug residence time may help develop better diagnostic, therapeutic agents

Research conducted at the Stony Brook University Institute for Chemical Biology & Drug Discovery that enhances the time a drug remains bound to its target, or residence time, may prove to be an important step in developing better diagnostic and therapeutic agents based partly on longer drug residence time.

17 Apr 2010

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Findings published today in The New England Journal of Medicine from a first-of-its-kind comparator trial evaluating the anti-tumor necrosis factor (TNF)-alpha biologic treatment REMICADE (infliximab) in the treatment of moderately to severely active Crohn's disease in patients who were naive to immunomodulator and biologic therapy, showed that a significantly greater proportion of patients receiving REMICADE achieved steroid-free remission and mucosal healing compared with patients receiving azathioprine.

16 Apr 2010

Newsweek examines tech startup's tools to fight malaria

Newsweek examines the work of Intellectual Ventures, a Seattle-based startup that is "trying to develop a computer model that could help eradicate malaria."

15 Apr 2010

Global maternal deaths decreased by more than 35% between 1980 and 2008, study finds

The number of maternal deaths around the world has decreased from more than 500,000 in 1980 to an estimated 342,900 in 2008, according to a Lancet study published online on Monday, the BBC reports.

15 Apr 2010

Drug boosting production of immune system protein worsens TB

An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health. The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online.

13 Apr 2010

San Diego Union-Tribune examines pharma's growing interest in neglected diseases

The San Diego Union-Tribune examines the pharmaceutical industry's growing interest in developing new treatments for what are known as "neglected diseases."

13 Apr 2010

Pregnancy-related deaths dropped by 35%: IHME study

The number of women dying from pregnancy-related causes has dropped by more than 35 percent in the past 30 years - from more than a half-million deaths annually in 1980 to about 343,000 in 2008, according to a new study by the Institute for Health Metrics and Evaluation at the University of Washington and collaborators at the University of Queensland.

13 Apr 2010

Study finds overall increase in developing country domestic health spending, some countries have reduced health budgets as donor funding increases

Researchers on Friday released a study in the Lancet that found while "[m]ost countries in Latin America, Asia and the Middle East doubled their health budgets," countries in sub-Saharan Africa appear to have trimmed their health spending as donors have boosted their health aid, the Associated Press/Washington Post reports.

12 Apr 2010

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Cempra Pharmaceuticals today announced poster presentations on its novel antibiotic CEM-101, a next-generation macrolide, and CEM-102, the company's proprietary front-loading oral dosing regimen of sodium fusidate, at the 20th European Congress of Clinical Microbiology and Infectious Disease, April 10 to 13, 2010, in Vienna Austria.

12 Apr 2010

We need social security fund on a global scale: The Lancet

We are in need of a social security fund on a global scale. That is what scientists of the Institute of Tropical Medicine Antwerp argue in a Viewpoint in the leading medical journal The Lancet. Such a 'Global Fund for Health' would make the use of international donor money a lot more transparent and efficient.

9 Apr 2010

WHO Director-General turns attention to conditions in slums to mark World Health Day

WHO Director-General Margaret Chan said addressing living conditions in the world's slums is important to improving urban health - the focus of World Health Day on Wednesday, Agence France-Presse reports.

9 Apr 2010

Pfizer to expand clinical trials in Asia, work on development of antibiotics for drug-resistant TB

The pharmaceutical company Pfizer said on Wednesday that it plans to increase the number of clinical trials it's conducting in Singapore by 10 percent as part of an effort "to design drugs for diseases prevalent in the region," Reuters reports.

9 Apr 2010

USAID: World Health Day 2010 focuses on world's growing urban population

This year the focus of World Health Day is on the world's growing urban population. The theme, "1000 cities, 1000 lives" provides an opportunity to highlight the work that is being done to improve health in urban settings. The unprecedented rate of urban growth has far outstripped the ability of these cities to provide infrastructure for new residents.

8 Apr 2010

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

Cempra Pharmaceuticals today announced its schedule of poster presentations at the 20th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna, Austria, on April 10-13, 2010.

8 Apr 2010

Tuberculosis News and Research

Latest Tuberculosis News and Research

World's smallest and lightest microscope for telemedicine applications

New USG strategy to combat malaria globally

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

Initial results of gallium-containing compound to treat serious infection presented at AACR 2010

Biomagnetics Diagnostics obtains handheld IOBS unit to detect pathogens

Report details progress in fighting malaria in Africa, notes funding shortfall

Enhancing drug residence time may help develop better diagnostic, therapeutic agents

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Newsweek examines tech startup's tools to fight malaria

Global maternal deaths decreased by more than 35% between 1980 and 2008, study finds

Drug boosting production of immune system protein worsens TB

San Diego Union-Tribune examines pharma's growing interest in neglected diseases

Pregnancy-related deaths dropped by 35%: IHME study

Study finds overall increase in developing country domestic health spending, some countries have reduced health budgets as donor funding increases

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

We need social security fund on a global scale: The Lancet

WHO Director-General turns attention to conditions in slums to mark World Health Day

Pfizer to expand clinical trials in Asia, work on development of antibiotics for drug-resistant TB

USAID: World Health Day 2010 focuses on world's growing urban population

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in